By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spring Bank Pharmaceuticals, Inc. 

113 Cedar Street
Ste S-7
Milford  Massachusetts  01757  U.S.A.
Phone: 508-473-5993 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Spring Bank Pharmaceuticals, Inc. Announces Financing Of $15 Million 11/21/2016 10:51:28 AM
Spring Bank Pharmaceuticals, Inc. Presents Data On STING Agonist SB 11285 At The AACR Special Conference On Tumor Immunology And Immunotherapy 10/20/2016 8:14:58 AM
Spring Bank Pharmaceuticals, Inc. To Present At Dawson James Securities 2016 Stock Growth Conference 10/13/2016 8:44:32 AM
Arrowhead Pharma (ARWR) And Spring Bank Pharmaceuticals, Inc. Announce Clinical Collaboration For ARC-520 And SB 9200 In Chronic Hepatitis B 10/6/2016 11:14:00 AM
Spring Bank Pharmaceuticals, Inc. Abstracts On STING Agonist SB 11285 Accepted For Poster Presentations At AACR Special Conference On Tumor Immunology And Immunotherapy 9/7/2016 10:07:58 AM
Spring Bank Pharmaceuticals, Inc. To Present At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City On September 13th, 2016 8/23/2016 8:03:47 AM
Spring Bank Pharmaceuticals, Inc. To Ring The Nasdaq Stock Market Opening Bell 8/2/2016 8:39:24 AM
Spring Bank Pharmaceuticals, Inc. Appoints Dr. Todd C. Brady To Its Board Of Directors 7/29/2016 8:29:14 AM
Spring Bank Pharmaceuticals, Inc. Reports Preclinical Data On The Use Of SB 9200 With Entecavir In The Woodchuck Model Of HBV 12/8/2015 11:46:30 AM
Spring Bank Pharmaceuticals, Inc. Announces Clinical Trial Collaboration With Gilead (GILD) For Hepatitis B (HBV) Phase 2 Clinical Trial 11/19/2015 6:12:21 AM
123
//-->